newsfilter
← Latest News
GlobeNewswire·

Harvard Bioscience Announces Second Quarter 2025 Financial Results

Reports Q2 2025 Revenues of $20.5M, Gross Margin of 56.4%, and Positive Cash Provided by OperationsThird Quarter 2025 Guidance Reflects Improved Operations and Strong Financial DisciplineNew Credit Amendment Signed,